Simcere Pharmaceutical Group
Manufacturing · China · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
no. 699-18 Xuanwu Xuanwu District Rd, Na...Phone Number
+86 2585566666Website
www.simcere.comRevenue
$941.7 MillionStock Symbol
2096Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Simcere Pharmaceutical Group
先声药业 is a pharmaceutical company focused on innovative drug development, particularly in oncology, neurology, autoimmune diseases, and cardiovascular conditions. The company emphasizes patient-first principles and collaborates globally to enhance its research and development pipeline. Its products include targeted therapies and treatments for various diseases, aiming to address unmet medical needs. The intended clients include healthcare providers and patients requiring advanced therapeutic options.Explore more
Simcere Pharmaceutical Group Org Chart
Get the full picture
Sign in to uncover key details.
YW
Manager, Laboratory & Procurement Operation
VL
Manager, Ir
YW
Manager, Finance
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Simcere Pharmaceutical Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Simcere Pharmaceutical Group has new funding data
Earning: See what the market has to say on Simcere Pharmaceutical Group recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Simcere Pharmaceutical Group
Product Launch: Get notified when Simcere Pharmaceutical Group launches new products
Website visits: Recent activity has been detected on your website
Simcere Pharmaceutical Group, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Simcere Pharmaceutical Group had a recent Job posting/layoffs
Check if Simcere Pharmaceutical Group has recently received funding, and reach out quickly before it becomes old news!
Check out if Simcere Pharmaceutical Group is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Simcere Pharmaceutical Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Simcere Pharmaceutical Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Simcere Pharmaceutical Group.
Simcere Pharmaceutical Group Tech Stack
A closer look at the technologies used by Simcere Pharmaceutical Group
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events
Left Company
Executive Move
Simcere Pharmaceutical Group News & Media
Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
SHANGHAI, June 12, 2026 /PRNewswire/ -- On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory study in the respiratory field, with the aim of developing...Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
– Rademikibart achieved rapid, durable efficacy results across all key endpoints through 52 weeks, with near‑maximal responses achieved in ~90% of patients –Simcere Pharmaceutical (02096.HK): Zhou Yunshu Appointed as Chief Executive Officer
Gelonghui,March 25th ┃ Simcere Pharmaceutical Group (02096.HK) announced that Zhou Yunshu has been appointed as Chief Executive Officer, effective from March 25, 2026. In this role, as a senior executive, he will be responsible for overseeing the overall management of the group's business operations. Zhou Yunshu reports to the board of directors and is subject to their guidance and supervision.Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that the results of a Phase 3 study of rademikibart in moderate-to-severe atopic dermatitis (AD) conducted by the Company’s partner in China, Simcere Pharmaceutical Co., Ltd. (Simcere), will be presented in the Late-Breaking R
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Simcere Pharmaceutical Group
Sign Up For FreeTo access detailed company insights
先声药业 is a pharmaceutical company focused on innovative drug development, particularly in oncology, neurology, autoimmune diseases, and cardiovascular conditions. The company emphasizes patient-first principles and collaborates globally to enhance its research and development pipeline. Its products include targeted therapies and treatments for vario... Read More
